Basic Information
| LncRNA/CircRNA Name | CCAT1 |
| Synonyms | CCAT1, CARLo-5, onco-lncRNA-40 |
| Region | GRCh38_8:127207382-127219268 |
| Ensemble | ENSG00000247844 |
| Refseq | NR_108049 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cholangiocarcinoma |
| ICD-0-3 | NA |
| Methods | qPCR |
| Sample | cholangiocarcinoma tissues |
| Expression Pattern | up-regulated |
| Function Description | The CCAT1 expression was significantly upregulated in CCA tumor tissues compared with adjacent normal tissues. The overall survival of CCA patients with high CCAT1 expression was worse. |
| Pubmed ID | 28387907 |
| Year | 2017 |
| Title | LncRNA CCAT1 as the unfavorable prognostic biomarker for cholangiocarcinoma |
External Links
| Links for CCAT1 | GenBank HGNC NONCODE |
| Links for cholangiocarcinoma | OMIM COSMIC |